World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
75
Citations
35120
World Ranking
1469
National Ranking
641

Luis Ostrosky-Zeichner publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Luis Ostrosky-Zeichner sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 244 publications — 63rd percentile

63% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Luis Ostrosky-Zeichner D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Luis Ostrosky-Zeichner sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 75 D-Index — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Research.com Recognitions

  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Fellow of the European Confederation of Medical Mycology (ECMM)
  • Fellow of the European Confederation of Medical Mycology (ECMM)

Overview

Luis Ostrosky-Zeichner is affiliated with The University of Texas Health Science Center at Houston in the United States. Their research primarily spans the field of Medicine, with a significant focus on Infectious Diseases, Epidemiology, Pulmonary and Respiratory Medicine, Surgery, and Cell Biology.

The scientist's recent notable publications include:

  • Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance (2020), published in The Lancet Infectious Diseases
  • Antifungal Susceptibility Testing: Current Approaches (2020), published in Clinical Microbiology Reviews
  • Global guideline for the diagnosis and management of rare yeast infections: an initiative of the ECMM in cooperation with ISHAM and ASM (2021), published in The Lancet Infectious Diseases
  • Invasive candidiasis (2024), published in Nature Reviews Disease Primers
  • Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications for COVID-19 immunity (2020), published in JCI Insight

Frequent co-authors in their research include:

  • Peter G. Pappas (20 co-authored publications)
  • George R. Thompson (16 co-authored publications)
  • Oliver A. Cornely (13 co-authored publications)
  • Andrej Spec (13 co-authored publications)
  • Martin Hoenigl (12 co-authored publications)

Ostrosky-Zeichner's research has appeared regularly in several publication venues, including:

  • Open Forum Infectious Diseases (26 publications)
  • Clinical Infectious Diseases (9 publications)
  • American Journal of Infection Control (9 publications)
  • The Lancet Infectious Diseases (5 publications)
  • Infectious Disease Clinics of North America (4 publications)

Their main research topics encompass:

  • Antifungal resistance and susceptibility
  • Fungal Infections and Studies
  • Nail Diseases and Treatments
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Plant Pathogens and Fungal Diseases
  • Infection Control and Ventilation
  • COVID-19 Clinical Research Studies

Ostrosky-Zeichner has received recognition as a Fellow of the European Confederation of Medical Mycology (ECMM), an award reflecting involvement in the professional medical mycology community. Their contributions reflect a strong focus on clinical infectious diseases, antifungal therapies, and emerging challenges within fungal infection management.

Best Publications

  • Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

    Peter G. Pappas;Carol A. Kauffman;David R. Andes;Cornelius J. Clancy

  • Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

    Peter G. Pappas;Carol A. Kauffman;David Andes;Daniel K. Benjamin

  • Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

    J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach

  • Invasive candidiasis

    Unknown

  • Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

    Peter G. Pappas;Carol A. Kauffman;David R. Andes;Cornelius J. Clancy

  • Multicenter Clinical Evaluation of the (1→3) β-D-Glucan Assay as an Aid to Diagnosis of Fungal Infections in Humans

    Luis Ostrosky-Zeichner;Barbara D. Alexander;Daniel H. Kett;Jose Antonio Vazquez

  • β-D-glucan as a diagnostic adjunct for invasive fungal infections: Validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

    Zekaver Odabasi;Gloria Mattiuzzi;Elihu Estey;Hagop Kantarjian

  • Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.

    Philipp Koehler;Matteo Bassetti;Arunaloke Chakrabarti;Sharon C.A. Chen;Sharon C.A. Chen

  • Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

    Ernst-Ruediger Kuse;Ploenchan Chetchotisakd;Clovis Arns da Cunha;Markus Ruhnke

  • Micafungin versus Caspofungin for Treatment of Candidemia and Other Forms of Invasive Candidiasis

    Peter G. Pappas;Coleman M. F. Rotstein;Robert F. Betts;Marcio Nucci

  • Isavuconazole Treatment for Mucormycosis: A Single-Arm Open-Label Trial and Case-Control Analysis

    Francisco M. Marty;Luis Ostrosky-Zeichner;Oliver A. Cornely;Kathleen M. Mullane

  • Combination Antifungal Therapy

    Melissa D. Johnson;Conan MacDougall;Luis Ostrosky-Zeichner;John R. Perfect

  • Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States

    Luis Ostrosky-Zeichner;John H. Rex;Peter G. Pappas;Richard J. Hamill

  • Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

    Brahm H. Segal;Raoul Herbrecht;David A. Stevens;David A. Stevens;Luis Ostrosky-Zeichner

  • An insight into the antifungal pipeline: selected new molecules and beyond.

    Luis Ostrosky-Zeichner;Arturo Casadevall;John N. Galgiani;Frank C. Odds

  • Amphotericin B: Time for a New “Gold Standard”

    Luis Ostrosky-Zeichner;Kieren A Marr;John H Rex;John H Rex;Stuart H Cohen

  • Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting

    L. Ostrosky-Zeichner;C. Sable;J. Sobel;B. D. Alexander

  • T2 Magnetic Resonance Assay for the Rapid Diagnosis of Candidemia in Whole Blood: A Clinical Trial

    Eleftherios Mylonakis;Cornelius J. Clancy;Luis Ostrosky-Zeichner;Kevin W. Garey

  • Invasive candidiasis in the intensive care unit.

    Luis Ostrosky-Zeichner;Peter G. Pappas

  • Correlation between E-Test, Disk Diffusion, and Microdilution Methods for Antifungal Susceptibility Testing of Fluconazole and Voriconazole

    Madonna J. Matar;Luis Ostrosky-Zeichner;Victor L. Paetznick;Jose R. Rodriguez

  • Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis (Clinical Infectious Diseases (2007) 45, (883-893))

    P. G. Pappas;C. M.F. Rotstein;R. F. Betts;M. Nucci

Frequent Co-Authors

John H. Rex
John H. Rex The University of Texas Health Science Center at Houston
Peter G. Pappas
Peter G. Pappas University of Alabama at Birmingham
Jose A. Vazquez
Jose A. Vazquez Augusta University
John R. Perfect
John R. Perfect Duke University
Oliver A. Cornely
Oliver A. Cornely University of Cologne
Thomas J. Walsh
Thomas J. Walsh Weill Cornell Medicine
David R. Andes
David R. Andes University of Wisconsin–Madison
Ana Espinel-Ingroff
Ana Espinel-Ingroff Virginia Commonwealth University Medical Center
Dimitrios P. Kontoyiannis
Dimitrios P. Kontoyiannis The University of Texas MD Anderson Cancer Center
Carol A. Kauffman
Carol A. Kauffman University of Michigan–Ann Arbor

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring microbiology opens doors to various related fields in healthcare and research. For those interested in the administrative side of medicine, the shortest online medical billing and coding certificate programs offer a quick way to enter the healthcare industry with flexible learning options.

Many students also consider broader online healthcare programs, which provide diverse pathways such as nursing, health informatics, or public health. These programs are designed to accommodate working professionals and can complement a microbiology background.

For those interested in public health leadership, finding the best easiest mph online programs to get into can simplify the admission process while still offering quality education. A Master’s in Public Health is a valuable addition for microbiologists aiming to impact community health.

Additionally, careers like the child life specialist role combine healthcare knowledge with emotional support skills, representing an alternative pathway that benefits from a strong scientific foundation.

Best Scientists Citing Luis Ostrosky-Zeichner

Trending Scientists

Recently Published Articles